Temozolomide Is Effective and Well Tolerated in Patients with Primary Vitreoretinal Lymphoma - Sorbonne Université
Article Dans Une Revue Blood Année : 2020

Temozolomide Is Effective and Well Tolerated in Patients with Primary Vitreoretinal Lymphoma

Pierre Soubeyran

Résumé

No abstract available

Dates et versions

hal-03892136 , version 1 (09-12-2022)

Identifiants

Citer

Marine Baron, Lisa Belin, Nathalie Cassoux, Christine Fardeau, Marion Blaizeau, et al.. Temozolomide Is Effective and Well Tolerated in Patients with Primary Vitreoretinal Lymphoma. Blood, 2020, 135 (20), pp.1811--1815. ⟨10.1182/blood.2019003073⟩. ⟨hal-03892136⟩
31 Consultations
0 Téléchargements

Altmetric

Partager

More